---
title: "Tolvaptan - Inappropriate adh syndrome"
sidebar: mydoc_sidebar
permalink: db06212-mesh-d007177-1.html
toc: false 
---


Path ID: `DB06212_MESH_D007177_1`
{% include image.html url="images/db06212-mesh-d007177-1.png" file="db06212-mesh-d007177-1.png" alt="db06212-mesh-d007177-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C116664 | tolvaptan | Drug |
| UniProt:P30518 | Vasopressin V2 receptor | Protein |
| REACT:R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins | Pathway |
| GO:0070295 | renal water absorption | BiologicalProcess |
| MESH:D007177 | Inappropriate ADH Syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolvaptan | NEGATIVELY REGULATES | Vasopressin V2 Receptor |
| Vasopressin V2 Receptor | PARTICIPATES IN | Vasopressin Regulates Renal Water Homeostasis Via Aquaporins |
| Vasopressin Regulates Renal Water Homeostasis Via Aquaporins | POSITIVELY REGULATES | Renal Water Absorption |
| Renal Water Absorption | POSITIVELY CORRELATED WITH | Inappropriate Adh Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB06212#mechanism-of-action](https://go.drugbank.com/drugs/DB06212#mechanism-of-action){:target="_blank"}